Howard P Sard

Organix, Inc.

$3,742,843

Attributed

$3,742,843

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $906.5K · FY2006–12

$1M$750K$500K$250K$0

'06

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$3,742,843 · 5

By mechanism

R44$2,392,796 · 2

R43$1,350,047 · 3

Top collaborators

No co-investigators on record.

Most similar at Organix, Inc.

Same institution · by research overlap

Anuradha Mahadevan$5,455,160

Others in their field

Top investigators on “Analog”

David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
Constance Ann Benson · University Of California, San Diego$84,289,569
Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
Robert Turner Schooley · University Of Colorado Denver$48,513,949
Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
John Hobbs · Suny At Stony Brook$41,239,084

Research focus

AnalogIndolesPharmacologic SubstanceProgramsIn VivoPharmaceutical PreparationsLeadEvaluationModificationMarketingAnimal ModelAdverse EffectsAffectIn VitroBiologicalLicensingAgonistCell NucleusGrantBaseMolecularDesignReceptorResources